TR200101082T2 - Bilinci veya algılama yeteneğini geliştirici bileşimler. - Google Patents

Bilinci veya algılama yeteneğini geliştirici bileşimler.

Info

Publication number
TR200101082T2
TR200101082T2 TR2001/01082T TR200101082T TR200101082T2 TR 200101082 T2 TR200101082 T2 TR 200101082T2 TR 2001/01082 T TR2001/01082 T TR 2001/01082T TR 200101082 T TR200101082 T TR 200101082T TR 200101082 T2 TR200101082 T2 TR 200101082T2
Authority
TR
Turkey
Prior art keywords
active ingredient
perception
alzheimer
disease
compositions
Prior art date
Application number
TR2001/01082T
Other languages
English (en)
Turkish (tr)
Inventor
Leonce Irma De Nijs Paul
Louis Julien Parys Wim
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of TR200101082T2 publication Critical patent/TR200101082T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
TR2001/01082T 1998-10-16 1999-10-12 Bilinci veya algılama yeteneğini geliştirici bileşimler. TR200101082T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98203454 1998-10-16

Publications (1)

Publication Number Publication Date
TR200101082T2 true TR200101082T2 (tr) 2001-09-21

Family

ID=8234219

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01082T TR200101082T2 (tr) 1998-10-16 1999-10-12 Bilinci veya algılama yeteneğini geliştirici bileşimler.

Country Status (20)

Country Link
EP (1) EP1121131A2 (sk)
JP (1) JP2002527469A (sk)
KR (1) KR20010072878A (sk)
CN (1) CN1367697A (sk)
AU (1) AU6472799A (sk)
BG (1) BG105302A (sk)
BR (1) BR9914419A (sk)
CA (1) CA2345767A1 (sk)
EE (1) EE200100136A (sk)
HK (1) HK1039745A1 (sk)
HR (1) HRP20010262A2 (sk)
HU (1) HUP0103781A3 (sk)
ID (1) ID28441A (sk)
IL (1) IL142588A0 (sk)
NO (1) NO20011403L (sk)
PL (1) PL348107A1 (sk)
SK (1) SK4592001A3 (sk)
TR (1) TR200101082T2 (sk)
WO (1) WO2000023057A2 (sk)
ZA (1) ZA200103081B (sk)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0102841D0 (en) * 2001-02-05 2001-03-21 Novartis Ag Organic compounds
AU2006201188B2 (en) * 2001-02-05 2007-11-15 Novartis Ag New use of iloperidone
WO2003037337A1 (en) * 2001-10-30 2003-05-08 Novartis Ag Depot formulations of iloperidone and a star polymer
GB0216416D0 (en) 2002-07-15 2002-08-21 Novartis Ag Organic compounds
US20040192754A1 (en) * 2003-03-24 2004-09-30 Shapira Nathan Andrew Methods for treating idiopathic hyperhidrosis and associated conditions
TW200501962A (en) * 2003-04-01 2005-01-16 Novartis Ag Use of carbamazepine derivatives for the treatment of agitation in dementia patients
US20050232990A1 (en) * 2003-12-31 2005-10-20 Garth Boehm Donepezil formulations
JP2008523058A (ja) * 2004-12-10 2008-07-03 アボット・ラボラトリーズ 縮合ビシクロ複素環置換キヌクリジン誘導体
WO2008055945A1 (en) 2006-11-09 2008-05-15 Probiodrug Ag 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
EP2091948B1 (en) 2006-11-30 2012-04-18 Probiodrug AG Novel inhibitors of glutaminyl cyclase
MX2009009234A (es) 2007-03-01 2009-12-01 Probiodrug Ag Uso nuevo de inhibidores de ciclasa de glutaminilo.
EP2865670B1 (en) 2007-04-18 2017-01-11 Probiodrug AG Thiourea derivatives as glutaminyl cyclase inhibitors
MX2007008642A (es) * 2007-07-16 2009-02-25 World Trade Imp Export Wtie Ag Composicion farmaceutica que comprende la combinacion de un agente derivado benzisoxazolico y un agente inhibidor reversible de la enzima colinesterasa, indicada para el control y tratamiento de trastornos psicoticos y demencias.
CN102905532A (zh) 2010-02-09 2013-01-30 约翰斯.霍普金斯大学 用于改善认知功能的方法和组合物
ES2586231T3 (es) 2010-03-03 2016-10-13 Probiodrug Ag Inhibidores de glutaminil ciclasa
AU2011226074B2 (en) 2010-03-10 2015-01-22 Vivoryon Therapeutics N.V. Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5)
EP2560953B1 (en) 2010-04-21 2016-01-06 Probiodrug AG Inhibitors of glutaminyl cyclase
US8530670B2 (en) 2011-03-16 2013-09-10 Probiodrug Ag Inhibitors
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
WO2014144801A1 (en) 2013-03-15 2014-09-18 Agenebio Inc. Methods and compositions for improving cognitive function
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
EA034167B8 (ru) 2015-05-22 2021-04-27 Эйджинбайо, Инк. Фармацевтические композиции леветирацетама пролонгированного высвобождения
DK3461819T3 (da) 2017-09-29 2020-08-10 Probiodrug Ag Inhibitorer af glutaminylcyklase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336675A (en) * 1991-05-14 1994-08-09 Ernir Snorrason Method of treating mania in humans
EP0515301A3 (en) * 1991-05-14 1993-06-16 Ernir Snorrason Improvements in benzodiazepine treatment by cholinesterterase inhibitors
JP4640888B2 (ja) * 1997-08-11 2011-03-02 ザ ユニヴァーシティー オブ サウス フロリダ 神経精神性疾患用ニコチンアンタゴニスト
RU2219924C2 (ru) * 1998-04-14 2003-12-27 Дзе Дженерал Хоспитал Корпорейшн Способ лечения нейропсихиатрических расстройств

Also Published As

Publication number Publication date
EP1121131A2 (en) 2001-08-08
PL348107A1 (en) 2002-05-06
SK4592001A3 (en) 2001-12-03
BR9914419A (pt) 2001-06-26
EE200100136A (et) 2002-06-17
HRP20010262A2 (en) 2002-06-30
CA2345767A1 (en) 2000-04-27
ID28441A (id) 2001-05-24
WO2000023057A3 (en) 2000-07-27
AU6472799A (en) 2000-05-08
HUP0103781A2 (hu) 2002-03-28
IL142588A0 (en) 2002-03-10
BG105302A (en) 2001-11-30
KR20010072878A (ko) 2001-07-31
CN1367697A (zh) 2002-09-04
HK1039745A1 (zh) 2002-05-10
NO20011403D0 (no) 2001-03-20
JP2002527469A (ja) 2002-08-27
ZA200103081B (en) 2002-07-12
NO20011403L (no) 2001-03-20
WO2000023057A2 (en) 2000-04-27
HUP0103781A3 (en) 2003-09-29

Similar Documents

Publication Publication Date Title
TR200101082T2 (tr) Bilinci veya algılama yeteneğini geliştirici bileşimler.
DE59106756D1 (de) Neuartige Antiepileptika.
HUP0102521A2 (hu) Sztilbénszármazékot és platina koordinációs vegyületet tartalmazó daganatellenes szer
DE60205234D1 (de) 1,2,3,4-tetrahydroisochinolin-derivate als urotensin ii rezeptor-antagonisten
TR200100172T2 (tr) Oral katı doz formunda eprosartan içeren biyolojik bakımdan kuvvetlendirilmiş formülasyonlar
ES2153975T3 (es) Derivados de pirimidona con actividad antifungica.
TR200101895T2 (tr) Cinsel rahatsızlıkların tedavisi.
ES2178036T3 (es) Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que le contienen.
ATE211384T1 (de) Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
ATE147981T1 (de) Verabreichung von lamotrigin zur behandlung von neuro-aids
MX9701946A (es) Solucion oftalmica transportadora.
DK0680326T3 (da) Farmaceutisk formulering af nikotinafhængighed.
FI964332A (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
TR199700878T1 (xx) Monamin oksidaz B inhibit�rleri i�eren farmakotik kompozisyonlar.
DE59609926D1 (de) Stabilisierte schilddrüsenhormonhaltige arzneimittel
TR200003736T2 (tr) Anksiyete durumlarına ya da depresyona bağlı değişikliklerin önlenmesi
TR200200449T2 (tr) Klonidin içeren etken madde kombinasyonu
EA199900876A1 (ru) Фармацевтические композиции против кашля
SE8103369L (sv) Antiperspirantkomposition innehallande en aluminiumklorid och en aluminiumzirkoniumhydroxiklorid som aktiva bestandsdelar och sett att inhibera perspiration
NZ319138A (en) Composition containing cytochrome complex III and fenazaquin for combatting parasitic fungi
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
MXPA03000606A (es) Derivados de benzofurano y su uso como agentes antibacterianos.
YU25001A (sh) Optički aktivan derivat piridil-4h-1,2,4-oksadiazina i njegova upotreba u proizvodnji lekova za tretiranje vaskularnih bolesti
DK0917460T3 (da) Cyclosporin-formulering
ATE309803T1 (de) Sphingomyelinase inhibitoren als wirkstoffe mit antiapoptotischer und antiseptischer wirkung